By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71



Company News
Kiadis Pharma Obtains Up To €15 Million Debt Financing From Kreos Capital 8/17/2017 7:33:12 AM
Kiadis Pharma To Present Information On The Design Of Its Phase III Trial With ATIR101 And Phase I/II Trial With ATIR201 At 43rd Annual Meeting Of The European Society For Blood And Marrow Transplantation 3/16/2017 7:33:19 AM
Kiadis Pharma To Present Atir10 Phase II Trial Data In Late Breaking Abstract At The International Society For Cellular Therapy (ISCT) 2017 Annual Meeting 3/13/2017 6:42:41 AM
Kiadis Pharma Issues Clinical And Regulatory Progress Update On ATIR101 And ATIR201 2/6/2017 7:08:50 AM
Kiadis Pharma Provides Update On Second Dose Trial (CR-AIR-008) With ATIR101 12/21/2016 1:06:59 PM
Kiadis Pharma Announces Initiation Of A Phase I/II Clinical Trial With ATIR201 For Thalassemia 12/15/2016 11:51:12 AM
Kiadis Pharma: Planned Management Team Changes 12/8/2016 10:59:30 AM
Kiadis Pharma Presents Positive 1-Year Follow-Up Data Of Its Pivotal Phase II Trial With ATIR101 12/6/2016 9:58:27 AM
One Year Data From Kiadis Pharma's Ongoing Phase II Trial With ATIR101 Will Be Presented At American Society of Hematology 2016 Annual Meeting 11/3/2016 8:52:15 AM
Kiadis Pharma Announces Financial Results For The Six Months Ended June 30, 2016 8/26/2016 8:36:29 AM